Navamedic ASA

Quotes

Musculoskeletal pain is a big health issue affecting quality of life for the vast majority of the population. As a health issue, it deserves more attention, and we have seen the need for more insights and knowledge. On the ThermaCare® website we will provide articles and interviews on this important subject, as well as information about ThermaCare as an effective and drug-free pain relief

Astrid T. Bratvedt

The addition of the antibiotics portfolio marked an important milestone for Navamedic and our expanding hospital and prescription drug offering. We are pleased to welcome Icepharma to join us in securing steady supply of these important products to Nordic hospitals,

says Kathrine Gamborg Andreassen, CEO of Navamedic.

Pick a time period -

Tags ( Active)

All Regulatory Non-Regulatory

Navamedic ASA: Enters into distribution agreement for ThermaCare® with Angelini Pharma

Tue, Mar 31, 2020 10:15 CET

Oslo, 3 March 2020 – Navamedic ASA (OSE: NAVA), today announces it has entered into an exclusive distribution agreement with Angelini Pharma for ThermaCare® in the Nordics and the strategically important Dutch market. With the agreement, Navamedic strengthens its position in the Consumer Health segment and enters the important pain category.“We are pleased to announce the agreement with Angelini Pharma for ThermaCare, expanding our portfolio of high-quality products to the benefit of our customers in the Nordics and Netherlands, underpinning the value of our insights, local expertise and

There are no items matching the current filter

There are no more items matching the current filter

Back to top

Share

Quotes

Navamedic ASA: Enters into distribution agreement for ThermaCare® with Angelini Pharma

Subscribe